Francisco Mesonero - Concepedia

Author

Francisco Mesonero

Hospital Universitario Ramón y Cajal ORCID

Also Known As

B Hernndez-Breijo, Bernd Bokemeyer, Edisa Armesto, F Mesonero, F. Mesonero, Francesco Malvestiti, Francisco J Medrano, Francisco Mesonero, Francisco Mesonero Gismero, Leticia Moreira

208

Publications

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Ramón y Cajal Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Hospital Universitario de La Princesa Complejo Hospitalario Universitario de Santiago Hospital General Universitario de Alicante Doctor Balmis

About

Francisco Mesonero is an author at Hospital Universitario Ramón y Cajal specializing in medicine, gastroenterology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	204
2	Gastroenterology	7	7	191
3	Epidemiology	3	3	67
4	Public Health	2	2	50
5	Emergency Medicine	1	1	17

Francisco Mesonero

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study Annalisa Berzigotti, Agustı́n Albillos, Càndid Villanueva, Hepatology	2016	315
Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry María Chaparro, A Garre, Francisco Mesonero, Journal of Crohn s and Colitis	2020	101
Short and long‐term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry María Chaparro, Ana Garre, Elena Ricart, Alimentary Pharmacology & Therapeutics	2018	95
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry María Chaparro, A Garre, Marisa Iborra, Journal of Crohn s and Colitis	2021	79
Real‐world short‐term effectiveness of ustekinumab in 305 patients with Crohn’s disease: results from the ENEIDA registry Marisa Iborra, Belén Beltrán, A Fernández-Clotet, Alimentary Pharmacology & Therapeutics	2019	70
Real‐world long‐term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry Marisa Iborra, Belén Beltrán, A Fernández-Clotet, Alimentary Pharmacology & Therapeutics	2020	65
Increased risk of thiopurine‐related adverse events in elderly patients with IBD Margalida Calafat, Míriam Mañosa, Fiorella Cañete, Alimentary Pharmacology & Therapeutics	2019	53
Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry Alicia Algaba, Iván Guerra, Elena Ricart, Digestive Diseases and Sciences Extraintestinal ManifestationsFunctional Gastrointestinal DisorderEneida RegistryGastroenterologyPathology	2020	50
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study Iván Guerra, Luís Bujanda, Jesús Castro, Journal of Crohn s and Colitis Psc-ibd PatientsMethods Psc-ibd PatientsGastroenterologyPathologyCholangiopathies	2019	49
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease Laurent Peyrin‐Biroulet, Jean‐François Rahier, Julien Kirchgesner, Clinical Gastroenterology and Hepatology Chronic Inflammatory DiseasesClinical EpidemiologyGastroenterologyOutcomes ResearchClinical Gastroenterology	2022	37

Page 1